Delivering on the Promise of Purity

Delivering on the Promise of PurityTM

Trehalose Injectable Excipient Molecular Structure used to stabilize proteins in biologics and therapeutics

Trehalose Dihydrate NF EP JP ChP

a, a Trehalose (Plant Derived) High Purity - Low Endotoxin - Low Metals NF, EP, JP, ChP

Molecular Formula

C12 H22O11 . 2H2O

CAS No

6138-23-4

Molecular Weight

378.33

Solubility in Water

68.9 g per 100 g at 20 °C

Boiling Point

675.4 °C

Melting Point

96.5 °C

Quality Level

Highest – Parenteral Excipient Grade cGMP

Suitable for Injectable Biologic & Vaccine formulation

Trehalose dihydrate is a sugar made from two glucose units linked by a strong α-1,1 bond that makes it stable in acidic and high-temperature conditions. Unlike other sugars it does not undergo glycation because its bonding keeps the glucose molecules in a closed-ring form. Trehalose is less soluble than sucrose but becomes more soluble at temperatures above 80°C. Its stability and resistance to breakdown have made it popular in biological preservation due to its cryoprotective properties.

 

Trehalose has a high glass transition temperature (Tg), typically around 115°C when in an anhydrous form. The glass transition temperature refers to the point at which a substance changes from a rubbery or viscous state to a glass-like, solid state. This property helps in preserving protein therapeutics by trapping proteins in a glassy matrix, effectively stabilizing them and preventing degradation.

At temperatures below the Tg, the molecules within the glassy matrix have limited mobility, which helps to reduce reactions that could otherwise damage the proteins, such as aggregation or denaturation. This makes trehalose particularly useful in protecting sensitive biologics during freeze-drying (lyophilization) and storage, where maintaining protein structure and function is critical for therapeutic effectiveness.

 

Low Endotoxin Trehalose is often used as excipient in protein based biologic therapeutics.  Special processing by regulated manufacturers is required to remove the naturally occurring endotoxin, bioburden, and trace metals to be considered parenteral excipient grade.

 

Pfanstiehl’s Trehalose dihydrate has been found to offer several benefits in the preservation of monoclonal antibodies, fusion proteins, vaccines, and stem cells.

Pfanstiehl Trehalose benefits include:

Cellular Protection

Trehalose has been shown to protect cells and biological materials from damage caused by freezing and thawing. Its presence helps maintain the structural integrity of cell membranes and prevents the formation of ice crystals, which can be detrimental to cells.

 

Protein Stabilization:

Trehalose is known for its protein-stabilizing properties. It can help maintain the conformational stability of proteins during freezing and thawing processes, reducing the risk of protein denaturation and aggregation.

 

Prevention of Freeze-Thaw Damage:

Administering highly Trehalose acts as a cryoprotectant, mitigating the harmful effects of freezing and thawing on cells and proteins. This is particularly important in the preservation of biological samples, where ice crystal formation and the associated cellular damage can be a significant concern.viscous formulations may require higher injection forces, leading to patient discomfort and potential issues with administration compliance.

 

Improved Viability and Functionality:

When used in cryopreservation, Trehalose has been shown to improve the viability and functionality of cells and biological molecules after thawing. This is crucial for maintaining the effectiveness of vaccines, antibodies, and other biopharmaceutical products.

 

Enhanced Long-Term Storage:

Trehalose allows for the long-term storage of biological materials at ultra-low temperatures without significant loss of viability or functionality. This is particularly valuable in biotechnology and pharmaceutical industries where the stability of products over time is crucial.

References/Citations:

Pfanstiehl Trehalose Citation Page

Highest cGMP Compendial Quality for your Highest Risk Applications

 

Pfanstiehl Brand High Purity – Low Endotoxin – Low Metals

  • Trehalose Dihydrate,

  • Trehalose Dihydrate (Low Glucose)

  • Trehalose Dihydrate Inhalation Grade

 

were developed specifically for biopharmaceutical formulation and commercial manufacturing and are produced under full ICH-Q7 cGMP conditions in the United States to the highest quality and purity standards.

 

Pfanstiehl Brand Trehalose is compliant with NF (National Formulary) EP (European) JP (Japanese) and ChP (Chinese) Pharmacopoeia

 

Because of these stringent manufacturing specifications and Pfanstiehl Quality Systems, you can be assured that Pfanstiehl’s Trehalose will be of the highest quality & consistency from batch to batch and the safest available for use in your manufacturing or research application.

Product Name:

Trehalose dihydrate

Quality Level:

Highest – Compendial Parenteral Excipient Grade GMP

Attributes:

Highest Purity

Lowest Endotoxin

Lowest Metals

Lowest Bioburden

Agency Pharmacopeia:

NF

EP

JP

ChP

Applications:

Parenteral Formulation

Liquid Formulation

Pharmaceutical Process

Biopharma Process

  • Product Name:

    Trehalose dihydrate

  • Quality Level:

    Highest – Compendial Parenteral Excipient Grade GMP

  • Attributes:

    Highest Purity

    Lowest Endotoxin

    Lowest Metals

    Lowest Bioburden

  • Agency Pharmacopeia:

    NF

    EP

    JP

    ChP

  • Applications:

    Parenteral Formulation

    Liquid Formulation

    Pharmaceutical Process

    Biopharma Process

Have Questions?

Please click the Contact Us box for:

  • Sample Requests

  • Price Quotes

  • Product Information

  • Quality Documentation

  • General Questions

Need Large Volumes?

10KG, 25KG, 50KG Pack Sizes Available – Contact Us for quote

What can we help you find?